Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Pharmaceuticals
The US government will pay $265 million under its Operation Warp Speed program to reserve capacity for manufacturing COVID-19 vaccines at Fujifilm Diosynth Biotechnologies’ facility in College Station, Texas. The government has a similar agreement with Emergent BioSolutions in Maryland. Fujifilm says some of the capacity will be allocated to the vaccine being developed by Novavax. Fujifilm recently signed a deal to manufacture the Novavax vaccine in Morrisville, North Carolina, for clinical trials before transferring production to Texas.
This article has been sent to the following recipient: